Australia enhances relationship with influential US healthtech association
28 September 2018
Pictured: MTPConnect CEO Dr Dan Grant with The Medical Alley Association CEO Shaye Mandle at the MedTech Conference.
MTPConnect has expanded its alliance with the influential The Medical Alley Association of Minnesota to open-up linkages for Australian researchers and firms in the United States.
Attending the 2018 MedTech Conference in Philadelphia, MTPConnect CEO Dr Dan Grant and Medical Alley Association CEO Shaye Mandle have signed an extended Memorandum of Understanding (MoU) to drive further collaboration between Australia and the United States.
Minnesota’s Medical Alley is home to more than 15,000 health establishments, including six Fortune 500 health technology companies, providing more than a half million jobs.
The extended agreement between MTPConnect and the Medical Alley Association means the two organisations will continue to work together on activities such as providing introductions and in-market support in their respective jurisdictions, exchanging information on key issues and trends, supporting inbound and outbound missions and the delivery of joint projects.
MTPConnect CEO Dr Dan Grant said the agreement opens the door to one of the world’s most important medtech markets.
“Minnesota’s Medical Alley is a globally renowned hub for medical device development and commercialisation and our agreement with the Medical Alley Association creates unique collaboration opportunities for Australia’s medtech researchers and firms,” Dr Grant said.
“The MoU extension we’ve signed here in Philadelphia builds on an already strong relationship and opens further connections between the exciting innovations taking place in Australia and the United States.
“The 19 Australian companies, research organisations, universities and industry bodies that are here are seeing first-hand what can be achieved through collaboration in the US and the MoU provides as mechanism to turn those opportunities into reality.”
Medical Alley Association CEO Shaye Mandle says he’s thrilled to be able to continue working with Australian researchers and firms.
“Our relationship with Australia is one of our most important and productive international alliances, dating back to the development of the pacemaker,” Mr Mandle said.
“With a renewed agreement in place with MTPConnect, we’ll be able to continue our collaborations with the Australian medical technology community to drive innovations which will ultimately help patients live better, longer.”
MTPConnect is leading a delegation of 19 Australian companies, research organisations, universities and industry bodies to The MedTech Conference. The mission is supported by the NSW, Victorian and Western Australian governments and is showcasing Australia’s outstanding innovative medical technology companies to potential investors and customers as well as creating new opportunities for international market access.
The full list of MTPConnect Australian delegation includes:
- Bionics Institute
- BioPacific Partners
- CoSec Consulting
- Design and Industry
- Five Corners
- IDE Group
- OncoRes Medical
- Osseointegration International
- Pharma Devices
- Preclinical Imaging and Research Laboratories (PIRL)
- Prime Financial Group
- Proteomics International
- The Actuator
- The Social Science
- The University of Newcastle
- The University of New South Wales
- The University of Western Australia